What is Valganciclovir?
Valganciclovir is an oral antiviral drug that is closely related to Ganciclovir. It is used to treat cytomegalovirus (CMV) infection in patients with HIV or AIDS and to prevent CMV infections in immunosuppressive patients such as immunosuppressive drugs after transplantation. The drug is only available as prescription and should be used under strict medical supervision.
The drug is known by various business names depending on the ground and manufacturers. In most countries, it is available as oral preparation, either as tablets or powder that are reconstructed before use in oral solution. The power of the tablet is usually 450 mg and oral solution, as soon as it is reconstructed, is 50 mg/ml. This can be accepted for a longer period of time and precisely the prescription instructions should be followed. Valganciclovir should be used with food. Dosage adjustments can be made in patients who have Renal dysfunction.
Cytomegalovirus is caused by a Herpes virus that usually does not cause a healthy immunocompetient personDaddy problems. In immunocompromised people, such as HIV or people on immunosuppressive drugs after organ transplantation, this disease can cause cytomegaloviroviovy retinitis. This is a serious condition that if you are not treated, it can lead to blindness.
VALGANCICLOVIR works paralyzing CMV. It blocks DNA polymerase, the enzyme that is necessary for the replication of the virus in the body, without which the condition cannot proceed. Essentially, the drug prevents long -term damage associated with CMV retinitis, which may include blindness. Early recognition of CMV and treatment is vital.
transplant patients are routinely prescribed immunosuppressive drugs to avoid the rejection of the donor organ. However, this may also reduce the patient's resistance to ER othinfection caused by the suppression of the immune system. Valganciclovir is used in these patients to prevent CMV infections.
as with any medicineThe Valganciclovir can interact with other medicines and be contraindicated in some patients with accompanying diseases. They should be discussed with a physician before starting therapy. Pregnancy, required pregnancy or lactation should also be discussed before treatment.
Valganciclovir can cause adverse effects. They may include headaches, sleep problems and some blood disorders, including anemia. The prescribed physician will monitor any patient taking Valganciclovir to make potential adverse effects. The default value of full blood numbers and routine blood monitoring during treatment can be recommended. If any side effects were experienced, the patient should immediately seek medical care.